| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | JW-7-52-1 | GDSC1000 | pan-cancer | AAC | 0.047 | 0.4 |
| mRNA | FH535 | GDSC1000 | pan-cancer | AAC | 0.031 | 0.4 |
| mRNA | tacrolimus | CTRPv2 | pan-cancer | AAC | -0.031 | 0.4 |
| mRNA | 16-beta-bromoandrosterone | CTRPv2 | pan-cancer | AAC | 0.033 | 0.4 |
| mRNA | clofarabine | CTRPv2 | pan-cancer | AAC | 0.026 | 0.4 |
| mRNA | PHA-793887 | GDSC1000 | pan-cancer | AAC | 0.025 | 0.4 |
| mRNA | Crizotinib | GDSC1000 | pan-cancer | AAC | -0.047 | 0.4 |
| mRNA | barasertib | CTRPv2 | pan-cancer | AAC | -0.028 | 0.4 |
| mRNA | BRD-K86535717 | CTRPv2 | pan-cancer | AAC | -0.066 | 0.4 |
| mRNA | PF-184 | CTRPv2 | pan-cancer | AAC | 0.029 | 0.4 |